Related Topics News -

     
 Title only   |   Print    Next page > 
     
《輪動華泰》醫藥股急升後回吐 AIDC電力概念有炒作

2026-10-07T  
《大行》高盛對醫藥及生物科技股投資評級及目標價(表)

2026-09-30T  
《大行》高盛:亞洲CDMO需求可見性提升 看好涉足早期研發及新興療法企業

2026-09-30T  
《大行》花旗:美對華藥企授權政策前景偏正面 看好創新藥及生物科技

2026-09-25T  
《大行》摩通:美國財政部或容許大部分中國醫藥對外授權交易 正關注「COINS法案」措辭

2026-09-22T  
傳美國放寬藥企對華投資限制 保留大部分藥品授權協議

2026-09-21T  
《大行》花旗:醫藥工業發展「十五五」規劃利好創新藥及醫療器械 首選石藥及藥明生物等

2026-09-21T  
內地十部門印發醫藥工業「十五五」規劃 2030年營收目標不少於3.5萬億人幣

2026-09-18T  
《輪動華泰》聯儲加息大市承壓 創新藥股逆市造好

2026-09-17T  
《大行》花旗:泰格醫藥監管不確定性消除 重申「買入」評級及首選股地位

2026-09-14T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.